177 related articles for article (PubMed ID: 22580118)
1. Five-year local control in a phase II study of hypofractionated intensity modulated radiation therapy with an incorporated boost for early stage breast cancer.
Freedman GM; Anderson PR; Bleicher RJ; Litwin S; Li T; Swaby RF; Ma CM; Li J; Sigurdson ER; Watkins-Bruner D; Morrow M; Goldstein LJ
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):888-93. PubMed ID: 22580118
[TBL] [Abstract][Full Text] [Related]
2. Prone breast intensity modulated radiation therapy: 5-year results.
Osa EO; DeWyngaert K; Roses D; Speyer J; Guth A; Axelrod D; Fenton Kerimian M; Goldberg JD; Formenti SC
Int J Radiat Oncol Biol Phys; 2014 Jul; 89(4):899-906. PubMed ID: 24867535
[TBL] [Abstract][Full Text] [Related]
3. Four-week course of radiation for breast cancer using hypofractionated intensity modulated radiation therapy with an incorporated boost.
Freedman GM; Anderson PR; Goldstein LJ; Ma CM; Li J; Swaby RF; Litwin S; Watkins-Bruner D; Sigurdson ER; Morrow M
Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):347-53. PubMed ID: 17379430
[TBL] [Abstract][Full Text] [Related]
4. Five-year results of whole breast intensity modulated radiation therapy for the treatment of early stage breast cancer: the Fox Chase Cancer Center experience.
Keller LM; Sopka DM; Li T; Klayton T; Li J; Anderson PR; Bleicher RJ; Sigurdson ER; Freedman GM
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):881-7. PubMed ID: 22909414
[TBL] [Abstract][Full Text] [Related]
5. Short-Course Hypofractionated Radiation Therapy With Boost in Women With Stages 0 to IIIa Breast Cancer: A Phase 2 Trial.
Ahlawat S; Haffty BG; Goyal S; Kearney T; Kirstein L; Chen C; Moore DF; Khan AJ
Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):118-125. PubMed ID: 26700706
[TBL] [Abstract][Full Text] [Related]
6. Quality of life after breast-conserving therapy and adjuvant radiotherapy for non-low-risk ductal carcinoma in situ (BIG 3-07/TROG 07.01): 2-year results of a randomised, controlled, phase 3 trial.
King MT; Link EK; Whelan TJ; Olivotto IA; Kunkler I; Westenberg AH; Gruber G; Schofield P; Chua BH;
Lancet Oncol; 2020 May; 21(5):685-698. PubMed ID: 32203696
[TBL] [Abstract][Full Text] [Related]
7. Accelerated hypofractionated adjuvant whole breast radiotherapy with concomitant photon boost after conserving surgery for early stage breast cancer: a prospective evaluation on 463 patients.
Cante D; Rosa La Porta M; Casanova-Borca V; Sciacero P; Girelli G; Pasquino M; Franco P; Ozzello F
Breast J; 2011; 17(6):586-93. PubMed ID: 21951485
[TBL] [Abstract][Full Text] [Related]
8. Hypofractionated Simultaneous Integrated Boost Radiotherapy Versus Conventional Fractionation Radiotherapy of Early Breast Cancer After Breast-Conserving Surgery: Clinical Observation and Analysis.
Dong J; Yang Y; Han D; Zhao Q; Liu C; Sun H; Wang Z; Lin H; Huang W
Technol Cancer Res Treat; 2021; 20():15330338211064719. PubMed ID: 34898315
[No Abstract] [Full Text] [Related]
9. Analysis of Outcomes Using Hypofractionated Tumor Bed Boost Combined With Hypofractionated Whole Breast Irradiation for Early-stage Breast Cancer.
Yu E; Huang D; Leonard K; Dipetrillo T; Wazer D; Hepel J
Clin Breast Cancer; 2017 Dec; 17(8):638-643. PubMed ID: 28629952
[TBL] [Abstract][Full Text] [Related]
10. Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer.
Touboul E; Buffat L; Belkacémi Y; Lefranc JP; Uzan S; Lhuillier P; Faivre C; Huart J; Lotz JP; Antoine M; Pène F; Blondon J; Izrael V; Laugier A; Schlienger M; Housset M
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(1):25-38. PubMed ID: 9989511
[TBL] [Abstract][Full Text] [Related]
11. Hypofractionated Versus Standard Fractionated Radiotherapy in Patients With Early Breast Cancer or Ductal Carcinoma In Situ in a Randomized Phase III Trial: The DBCG HYPO Trial.
Offersen BV; Alsner J; Nielsen HM; Jakobsen EH; Nielsen MH; Krause M; Stenbygaard L; Mjaaland I; Schreiber A; Kasti UM; Overgaard J;
J Clin Oncol; 2020 Nov; 38(31):3615-3625. PubMed ID: 32910709
[TBL] [Abstract][Full Text] [Related]
12. Early-stage breast cancer treated with 3-week accelerated whole-breast radiation therapy and concomitant boost.
Chadha M; Woode R; Sillanpaa J; Lucido D; Boolbol SK; Kirstein L; Osborne MP; Feldman S; Harrison LB
Int J Radiat Oncol Biol Phys; 2013 May; 86(1):40-4. PubMed ID: 23290443
[TBL] [Abstract][Full Text] [Related]
13. Phase I-II study of hypofractionated simultaneous integrated boost using volumetric modulated arc therapy for adjuvant radiation therapy in breast cancer patients: a report of feasibility and early toxicity results in the first 50 treatments.
Scorsetti M; Alongi F; Fogliata A; Pentimalli S; Navarria P; Lobefalo F; Garcia-Etienne C; Clivio A; Cozzi L; Mancosu P; Nicolini G; Vanetti E; Eboli M; Rossetti C; Rubino A; Sagona A; Arcangeli S; Gatzemeier W; Masci G; Torrisi R; Testori A; Alloisio M; Santoro A; Tinterri C
Radiat Oncol; 2012 Aug; 7():145. PubMed ID: 22929062
[TBL] [Abstract][Full Text] [Related]
14. Local recurrence rates in breast cancer patients treated with intraoperative electron-boost radiotherapy versus postoperative external-beam electron-boost irradiation. A sequential intervention study.
Reitsamer R; Peintinger F; Kopp M; Menzel C; Kogelnik HD; Sedlmayer F
Strahlenther Onkol; 2004 Jan; 180(1):38-44. PubMed ID: 14704843
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcomes of patients with conserved breast cancer treated with adjuvant hypofractionated prone breast intensity-modulated radiation therapy.
Gortman AM; Aherne NJ; Amalaseelan J; Last A; Westhuyzen J; Chamberlain L; Shakespeare TP
J Med Imaging Radiat Oncol; 2020 Dec; 64(6):845-851. PubMed ID: 32543013
[TBL] [Abstract][Full Text] [Related]
16. Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy.
Freedman G; Fowble B; Hanlon A; Nicolaou N; Fein D; Hoffman J; Sigurdson E; Boraas M; Goldstein L
Int J Radiat Oncol Biol Phys; 1999 Jul; 44(5):1005-15. PubMed ID: 10421533
[TBL] [Abstract][Full Text] [Related]
17. Breast preservation in stage I and II carcinoma of the breast. The University of Chicago experience.
Heimann R; Powers C; Halpem HJ; Michel AG; Ewing CA; Wyman B; Recant W; Weichselbaum RR
Cancer; 1996 Oct; 78(8):1722-30. PubMed ID: 8859185
[TBL] [Abstract][Full Text] [Related]
18. Five year outcome of 145 patients with ductal carcinoma in situ (DCIS) after accelerated breast radiotherapy.
Ciervide R; Dhage S; Guth A; Shapiro RL; Axelrod DM; Roses DF; Formenti SC
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):e159-64. PubMed ID: 22579378
[TBL] [Abstract][Full Text] [Related]
19. Weekly concomitant boost in adjuvant radiotherapy for patients with early breast cancer: preliminary results on feasibility.
Corvò R; Giudici S; Maggio F; Bevegni M; Sampietro C; Lucido MR; Orsatti M
Tumori; 2008; 94(5):706-11. PubMed ID: 19112945
[TBL] [Abstract][Full Text] [Related]
20. A Comparative Study of Daily 3-Gy Hypofractionated and 1.8-Gy Conventional Breast Irradiation in Early-Stage Breast Cancer.
Lee SW; Kim YJ; Shin KH; Kim K; Chie EK; Han W; Im SA; Jung SY; Lee KS; Lee ES
Medicine (Baltimore); 2016 May; 95(19):e3320. PubMed ID: 27175630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
